TB Vaccine Trial Results Offer Potential for BCG Revaccination, Hope for Subunit Vaccines
February 20th 2018\Nonprofit organization Aeras announced results from an innovative clinical trial that provides encouraging new evidence that TB vaccines could prevent sustained infections in high-risk adolescents.
Typhoid Outbreak: Genetic Cause of Extensive Drug Resistance Found
February 20th 2018The genetic cause behind a strain of typhoid's resistance to five classes of antibiotics has been uncovered by scientists at the Wellcome Sanger Institute and their collaborators at Public Health England and Aga Khan University, Pakistan.
Researchers Compare Governance Approaches for the Control of Antimicrobial Resistance
February 20th 2018A review by Birgand, et al. (2018) provides an analysis of governance approaches within healthcare systems including: priority setting, performance monitoring and accountability for AMR prevention in three European countries: England, France and Germany.
First Multiplex Test for Tickborne Diseases
February 16th 2018A new blood test called the Tick-Borne Disease Serochip (TBD Serochip) promises to revolutionize the diagnosis of tickborne disease by offering a single test to identify and distinguish between Borrelia burgdorferi and seven other tickborne pathogens.
Expanding Hepatitis C Testing to All Adults is Cost-Effective and Improves Outcomes
February 16th 2018According to a new study, screening all adults for hepatitis C (HCV) is a cost-effective way to improve clinical outcomes of HCV and identify more infected people compared to current recommendations.
New Class of Drug to Treat Herpes Simplex Virus Infection
February 15th 2018Researchers at the University of Illinois at Chicago have now identified a small drug molecule that can clear the HSV-1 infection in the cells of the cornea and works completely differently than the currently-available drugs, making it a promising potential option for patients who have developed resistance.